000 01802 a2200505 4500
005 20250518002527.0
264 0 _c20190206
008 201902s 0 0 eng d
022 _a1553-7374
024 7 _a10.1371/journal.ppat.1007307
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBamford, Connor G G
245 0 0 _aA polymorphic residue that attenuates the antiviral potential of interferon lambda 4 in hominid lineages.
_h[electronic resource]
260 _bPLoS pathogens
_c10 2018
300 _ae1007307 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntiviral Agents
_xtherapeutic use
650 0 4 _aBiological Evolution
650 0 4 _aCardiovirus Infections
_xdrug therapy
650 0 4 _aCells, Cultured
650 0 4 _aEncephalomyocarditis virus
_xdrug effects
650 0 4 _aGene Expression Regulation
650 0 4 _aHepacivirus
_xdrug effects
650 0 4 _aHepatitis C
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aInterleukins
_xgenetics
650 0 4 _aPan troglodytes
650 0 4 _aPolymorphism, Single Nucleotide
650 0 4 _aSpecies Specificity
650 0 4 _aZika Virus
_xdrug effects
650 0 4 _aZika Virus Infection
_xdrug therapy
700 1 _aAranday-Cortes, Elihu
700 1 _aFilipe, Ines Cordeiro
700 1 _aSukumar, Swathi
700 1 _aMair, Daniel
700 1 _aFilipe, Ana da Silva
700 1 _aMendoza, Juan L
700 1 _aGarcia, K Christopher
700 1 _aFan, Shaohua
700 1 _aTishkoff, Sarah A
700 1 _aMcLauchlan, John
773 0 _tPLoS pathogens
_gvol. 14
_gno. 10
_gp. e1007307
856 4 0 _uhttps://doi.org/10.1371/journal.ppat.1007307
_zAvailable from publisher's website
999 _c28926221
_d28926221